Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia - Concepedia

Concepedia

Publication | Open Access

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

DOI Full Paper Access

951

Citations

39

References

2009

Year

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Norbert Gattermann, Ulrich Germing, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour,

Journal of Clinical Oncology

Abstract

In older adult patients with low marrow blast count (20% to 30%) WHO-defined AML, azacitidine significantly prolongs OS and significantly improves several patient morbidity measures compared with CCR.

References

	Year	Citations

Page 1